Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays

详细信息    查看全文

• 作者：Lei Guo (1) (2)
  Yuqin Qiu (1)
  Jianmin Chen (1) (2)
  Suohui Zhang (1)
  Bai Xu (1)
  Yunhua Gao (1)
  
• 关键词：Transcutaneous immunization ; Microneedle ; Hydrogel formulation ; Hepatitis B surface antigen (HBsAg)
• 刊名：Biomedical Microdevices
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：15
• 期：6
• 页码：1077-1085
• 全文大小：
• 作者单位：Lei Guo (1) (2)
  Yuqin Qiu (1)
  Jianmin Chen (1) (2)
  Suohui Zhang (1)
  Bai Xu (1)
  Yunhua Gao (1)
  
  1. Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China
  2. Graduate University of Chinese Academy of Sciences, Beijing, 100049, China
  
• ISSN：1572-8781

文摘

Transcutaneous immunization (TCI) has many advantages compared with needle-based administrations. But the conventional TCI shows poor permeation of antigens across the skin barrier. In this study, Functional MicroArray (FMA) system was used to poke the skin and increase the permeability, and the hydrogel patch formulation was used as the carrier for transdermal delivery of hepatitis B surface antigen (HBsAg) and cholera toxin B (CTB) as an adjuvant. In vitro permeation of antigen was studied using porcine ear skin and rat abdominal skin. The results showed that FMA system could significantly increase the permeation of HBsAg across skin compared with conventional TCI. HBsAg loaded hydrogel formulation exhibited better antigenic thermostability than the liquid formulation. In vivo immunization studies were performed in mice, and the serum IgG titer, IgG2a/IgG1 ratio were measured. The results showed that TCI with FMA induced more potent immune responses than the groups without FMA pretreatment. CTB adjuvanted TCI group could induce higher IgG titers compared with the group without CTB. Furthermore, TCI group can maintain a longer duration of stable IgG titers compared with the intramuscular injection (IM) group. In conclusion, the FMA/hydrogel system was proved to be a potential vaccination strategy against hepatitis B virus.